Towards Healthcare Research & Consulting
Coronary Stent Market
Updated Date: 08 July 2026   |   Report Code: 5152
[email protected] +1 804-441-9344
Download Sample Order Now

Coronary Stent Market Trends, Share, and Growth Analysis 2035

According to Shivani Zoting, who specializes in cardiovascular medical devices and interventional cardiology markets, with 5+ years of experience in market research and industry analysis, the coronary stent market is set to grow from US$ 9.65 billion in 2025 to US$ 13.74 billion by 2035 at a 3.6% CAGR, driven by the rising burden of coronary artery disease and continuous advances in stent technologies. Her research highlights drug-eluting stents as the leading segment, while bioresorbable scaffold systems are expected to record the fastest growth. She identifies North America as the dominant regional market, with Asia Pacific emerging as the fastest-growing region, and notes that leading companies including Abbott, Medtronic, Boston Scientific, Terumo, BD, Biotronik, B. Braun, Cook, and MicroPort Scientific Corporation continue to shape the competitive landscape through innovation and strategic expansion.

Last Updated : 08 July 2026 Category: Medical Devices Insight Code: 5152 Format: PDF / PPT / Excel

Content

Introduction

  • Research Objective
  • Scope of the Study
  • Definition and Taxonomy

Research Methodology

  • Research Approach
  • Data Sources
  • Assumptions

Executive Summary

  • Synopsis
  • Analyst Recommendations

Market Overview 

  • Market Dynamics
    • Market Drivers
    • Market Restraints
    • Market Opportunities
  • Value Chain Analysis
    • Raw Material Sourcing
    • Manufacturing Process
    • Logistics & Transportation
    • Buyer Preferences
  • Trends
    • Market Trends
    • Technological Trends
  • Porter’s Five Forces Analysis
    • Bargaining Power of Suppliers
    • Bargaining Power of Buyers
    • Threat of Substitute
    • Threat of New Entrants
    • Degree of Competition
  • PESTLE Analysis for 5 Leading Countries
    • Regulatory Framework for Leading Countries/Regions
    • Supply Demand Analysis
    • Production & Consumption Statistics
    • Export Import Statistics
    • Price Trend Analysis

Global Coronary Stent Market Assessment

  • Overview
  • Global Coronary Stent Market Size Value (US$) and Volume (Billion Tons), by Type (2021 – 2033)
    • Bare Metal Stents (BMS)
    • Drug-eluting Stents (DES)
    • Bioresorbable Scaffold System (BRS)
    • Drug-eluting Balloons (DEB)
  • Global Coronary Stent Market Size Value (US$) and Volume (Billion Tons), by End Use (2021 – 2033)
    • Hospitals & Ambulatory Surgical Centers
    • Specialty Clinics
    • Others
  • Global Coronary Stent Market Size Value (US$) and Volume (Billion Tons), by Geography (2021 – 2033)
    • North America
    • Europe
    • Asia Pacific
    • Middle East and Africa
    • South America

North America Coronary Stent Market Assessment

  • Overview
  • North America Coronary Stent Market Size Value (US$) and Volume (Billion Tons), by Type (2021 – 2033)
    • Bare Metal Stents (BMS)
    • Drug-eluting Stents (DES)
    • Bioresorbable Scaffold System (BRS)
    • Drug-eluting Balloons (DEB)
  • North America Coronary Stent Market Size Value (US$) and Volume (Billion Tons), by End Use (2021 – 2033)
    • Hospitals & Ambulatory Surgical Centers
    • Specialty Clinics
    • Others

Europe Coronary Stent Market Assessment

  • Overview
  • Europe Coronary Stent Market Size Value (US$) and Volume (Billion Tons), by Type (2021 – 2033)
    • Bare Metal Stents (BMS)
    • Drug-eluting Stents (DES)
    • Bioresorbable Scaffold System (BRS)
    • Drug-eluting Balloons (DEB)
  • Europe Coronary Stent Market Size Value (US$) and Volume (Billion Tons), by End Use (2021 – 2033)
    • Hospitals & Ambulatory Surgical Centers
    • Specialty Clinics
    • Others

Asia Pacific Coronary Stent Market Assessment

  • Overview
  • Asia Pacific Coronary Stent Market Size Value (US$) and Volume (Billion Tons), by Type (2021 – 2033)
    • Bare Metal Stents (BMS)
    • Drug-eluting Stents (DES)
    • Bioresorbable Scaffold System (BRS)
    • Drug-eluting Balloons (DEB)
  • Asia Pacific Coronary Stent Market Size Value (US$) and Volume (Billion Tons), by End Use (2021 – 2033)
    • Hospitals & Ambulatory Surgical Centers
    • Specialty Clinics
    • Others

Middle East and Africa Coronary Stent Market Assessment

  • Overview
  • Middle East and Africa Coronary Stent Market Size Value (US$) and Volume (Billion Tons), by Type (2021 – 2033)
    • Bare Metal Stents (BMS)
    • Drug-eluting Stents (DES)
    • Bioresorbable Scaffold System (BRS)
    • Drug-eluting Balloons (DEB)
  • Middle East and Africa Coronary Stent Market Size Value (US$) and Volume (Billion Tons), by End Use (2021 – 2033)
    • Hospitals & Ambulatory Surgical Centers
    • Specialty Clinics
    • Others

South America Coronary Stent Market Assessment

  • Overview
  • South America Coronary Stent Market Size Value (US$) and Volume (Billion Tons), by Type (2021 – 2033)
    • Bare Metal Stents (BMS)
    • Drug-eluting Stents (DES)
    • Bioresorbable Scaffold System (BRS)
    • Drug-eluting Balloons (DEB)
  • South America Coronary Stent Market Size Value (US$) and Volume (Billion Tons), by End Use (2021 – 2033)
    • Hospitals & Ambulatory Surgical Centers
    • Specialty Clinics
    • Others

Company Profiles

  • Biotronik SE & Co. KG
    • Company Overview
    • Geographic Footprints
    • Financial Performance
    • Product Portfolio
    • SWOT Analysis
    • R&D Efforts
    • Recent Developments & Strategic Collaborations
      • Product Launch/M&A/Technical Collaboration
  • Cook
  • Terumo Corporation
  • Abbott
  • BD
  • MicroPort Scientific Corporation
  • B. Braun Melsungen AG
  • Boston Scientific Corporation
  • Medtronic

Conclusion & Recommendations

FAQ's

Answer : The coronary stent market, valued at USD 9.65 billion in 2025 and USD 10.00 billion in 2026, is projected to reach USD 13.74 billion by 2035 at a CAGR of 3.6%.

Answer : Drug-eluting stents (DES) dominated the market with a 60% share in 2023 due to their superior ability to reduce restenosis.

Answer : National Institute of Health, British Health Foundation and World Health Organization.
Any Questions

Meet the Team

Shivani Zoting is a dedicated research analyst specializing in the healthcare industry. With a strong academic foundation, a B.Sc. in Biotechnology and an MBA in Pharmabiotechnology, she brings a unique blend of scientific understanding and strategy.

Learn more about Shivani Zoting

Aditi Shivarkar is a seasoned professional with over 14 years of experience in healthcare market research. As a content reviewer, Aditi ensures the quality and accuracy of all market insights and data presented by the research team.

Learn more about Aditi Shivarkar